Accretion Nutraveda
Table of Contents
- 01 IPO Description
- 02 IPO Parameters
- 03 IPO Roadmap
- 04 GMP History
- 05 Accretion Nutraveda IPO – Key Details
- 06 Accretion Nutraveda IPO – Market Lot Details
- 07 Accretion Nutraveda IPO – Reservation Details
- 08 Accretion Nutraveda IPO – Anchor Investors
- 09 Accretion Nutraveda IPO – Important Dates
- 10 Accretion Nutraveda IPO – Promoters & Holding Pattern
- 11 Accretion Nutraveda IPO – Objects of the Issue & Utilisation of Proceeds
- 12 About Accretion Nutraveda IPO
- 13 Accretion Nutraveda IPO – Company Financial Report
- 14 Accretion Nutraveda IPO – Valuation (FY2025)
- 15 Accretion Nutraveda IPO – Peer Group Comparison
- 16 IPO Lead Managers aka Merchant Bankers
IPO PARAMETERS
IPO ROADMAP
Grey Market Premium HISTORY
| Date | GMP (₹) | Daily Change | Gain (%) |
|---|---|---|---|
| 04 Feb 2026 | ₹69.00 | +₹53.00 | 53.49% |
| 03 Feb 2026 | ₹16.00 | +₹10.00 | 12.40% |
| 02 Feb 2026 | ₹6.00 | - | 4.65% |
Accretion Nutraveda IPO – Key DETAILS
| IPO Open Date | January 27, 2026 |
| IPO Close Date | January 30, 2026 |
| Face Value | ₹10 per Equity Share |
| Price Band | ₹122 – ₹129 per Share |
| Issue Size | Approx ₹24.77 Crores |
| Fresh Issue | Approx ₹24.77 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | BSE SME |
Accretion Nutraveda IPO – Market Lot DETAILS
| Application | Lot Size | Shares | Amount (₹) |
|---|---|---|---|
| Retail Minimum | 2 | 2,000 | 2,58,000 |
| Retail Maximum | 2 | 2,000 | 2,58,000 |
| S‑HNI Minimum | 3 | 3,000 | 3,87,000 |
| S‑HNI Maximum | 7 | 7,000 | 9,03,000 |
| B‑HNI Minimum | 8 | 8,000 | 10,32,000 |
Accretion Nutraveda IPO – Reservation DETAILS
| Investor Category | Shares Offered | Percentage (%) |
|---|---|---|
| Anchor Investors | – | – |
| QIB (Ex‑Anchor) | 9,08,000 | 47.29% |
| NII | 2,76,000 | 14.37% |
| Retail | 6,40,000 | 33.33% |
Accretion Nutraveda IPO – Anchor INVESTORS
| Anchor Bidding Date | January 2026 |
| Anchor Investors List | – |
| Shares Offered to Anchor Investors | – |
| Anchor Size | – |
| Lock‑in Period (50% – 30 Days) | 2026 |
| Lock‑in Period (50% – 90 Days) | 2026 |
Accretion Nutraveda IPO – Important DATES
| IPO Open Date | January 27, 2026 |
| IPO Close Date | January 30, 2026 |
| Basis of Allotment | February 2, 2026 |
| Refunds Initiation | February 3, 2026 |
| Credit to Demat Account | February 3, 2026 |
| IPO Listing Date | February 4, 2026 |
| IPO Bidding Cut‑off Time | January 30, 2026 – 5:00 PM |
Accretion Nutraveda IPO – Promoters & Holding PATTERN
Promoters: Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel
| Particulars | Shares | Shareholding (%) |
|---|---|---|
| Promoter Holding (Pre‑Issue) | 53,20,000 | 100.00% |
| Promoter Holding (Post‑Issue) | 72,40,000 | 73.48% |
Accretion Nutraveda IPO – Objects of the Issue & Utilisation of PROCEEDS
| Purpose | Amount (₹ Cr) |
|---|---|
| Purchase of machineries for automation in existing manufacturing unit | 4.22 |
| Purchase of machineries for new manufacturing setup | 8.03 |
| Funding working capital requirements of the company | 5.50 |
| General Corporate Purpose | – |
About Accretion Nutraveda IPO
Accretion Nutraveda, since its incorporation in 2021, has been focused on the manufacturing of Ayurvedic and Nutraceutical products in India. It offers Ayurvedic and Nutraceutical products in various dosages and forms, like tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.
The company serves its customers in India as well as in international countries like Sri Lanka, Singapore, and the USA. The firm blends Ayurvedic and science to offer treatments for various areas, like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness. The company runs a 10,763 sq. ft. manufacturing facility situated in Gujarat. Its unit includes modern infrastructure and quality control systems.
Accretion Nutraveda IPO – Company Financial REPORT
| Period Ended | Revenue (₹ Cr) | Expense (₹ Cr) | PAT (₹ Cr) | Assets (₹ Cr) |
|---|---|---|---|---|
| FY 2023 | 3.07 | 2.78 | 0.28 | 4.06 |
| FY 2024 | 5.20 | 4.28 | 0.82 | 4.64 |
| FY 2025 | 16.06 | 12.87 | 2.61 | 10.86 |
Accretion Nutraveda IPO – Valuation (FY2025)
| KPI | Values |
|---|---|
| ROE | 81.22% |
| ROCE | 36.98% |
| EBITDA Margin | 22.79% |
| PAT Margin | 16.33% |
| Debt to Equity Ratio | – |
| Earning Per Share (EPS) | ₹7.19 (Basic) |
| Price / Earnings (P/E) | N/A |
| Return on Net Worth (RoNW) | 48.85% |
| Net Asset Value (NAV) | ₹14.72 |
Accretion Nutraveda IPO – Peer Group COMPARISON
| Company | EPS (₹) | P/E Ratio | RoNW (%) | NAV (₹) | Income (₹ Cr) |
|---|---|---|---|---|---|
| Walpar Nutritions Ltd. | 1.80 | 23.94 | 11.27% | 13.65 | 60.26 |
| Influx Healthtech Limited | 7.31 | 25.93 | 36.72% | 5.31 | 104.99 |
IPO Lead Managers aka Merchant BANKERS
- Sobhagya Capital Options Pvt. Ltd.